← Back

UK MHRA · UK · 29 Jun 2026 · Guidance

Guidance: Innovation Accelerator

AI-generated summary

The UK MHRA's Innovation Accelerator service provides developers of innovative medicines, medical devices (including software), and blood transfusion components with access to MHRA scientific expertise, regulatory guidance, and enhanced advice. The service combines the Innovation Office, Regulatory Advice Service for Regenerative Medicines, Regulatory Science, and horizon scanning, and supports the Innovative Licensing and Access Pathway. The guidance includes updated contact details and links to horizon scanning case studies on actionable signals, machine learning practices, and adeno-associated virus gene therapies.

From UK MHRA

Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.

The Innovation Accelerator service will help provide innovators access to MHRA scientific expertise and regulatory guidance, helping developers of innovative products (medicines, medical devices (including software) and blood components for transfusion) connect more dynamically with an enhanced advice and signposting service.

The Innovation Accelerator functions bring together the Innovation Office, the Regulatory Advice Service for Regenerative Medicines (RASRM), Regulatory Science and horizon scanning. It also supports the delivery of the Innovative Licensing and Access Pathway (ILAP).

Updated attachment with contact details and further information on Innovation Accelerator

Added link to 'Horizon Scanning Case Study: What is an Actionable Horizon Scanning Signal (AHSS)?'

Added link to 'Horizon Scanning Case Study: Guiding principles that can inform the development of Good Machine Learning Practice'

A link to the recently published Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies has been included as an example.

Excerpt from the official page. The original is authoritative.